Floris A. de Jong

2.6k total citations
54 papers, 1.9k citations indexed

About

Floris A. de Jong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Floris A. de Jong has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 19 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Floris A. de Jong's work include Cancer therapeutics and mechanisms (19 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Lung Cancer Research Studies (9 papers). Floris A. de Jong is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Lung Cancer Research Studies (9 papers). Floris A. de Jong collaborates with scholars based in Netherlands, United States and Taiwan. Floris A. de Jong's co-authors include Jaap Verweij, Ron H.J. Mathijssen, Alex Sparreboom, Walter J. Loos, Maja J.A. de Jonge, Jessica M. van der Bol, Li‐Tzong Chen, Jens T. Siveke, Metin Tascilar and Bruce Belanger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Floris A. de Jong

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Floris A. de Jong Netherlands 23 1.2k 648 331 229 207 54 1.9k
Stacy S. Shord United States 28 1.0k 0.9× 714 1.1× 265 0.8× 133 0.6× 159 0.8× 69 2.7k
Donna S. Cox United States 26 739 0.6× 881 1.4× 240 0.7× 214 0.9× 116 0.6× 55 2.4k
Clara Chen United States 24 832 0.7× 604 0.9× 401 1.2× 69 0.3× 116 0.6× 101 2.6k
Hyeong‐Seok Lim South Korea 21 795 0.7× 622 1.0× 252 0.8× 228 1.0× 194 0.9× 91 1.9k
Mansour Al‐Moundhri Oman 24 701 0.6× 501 0.8× 283 0.9× 47 0.2× 151 0.7× 88 1.8k
Junichi Sakamoto Japan 24 735 0.6× 586 0.9× 684 2.1× 118 0.5× 82 0.4× 98 2.2k
Hyun Jo Youn South Korea 25 674 0.6× 634 1.0× 208 0.6× 134 0.6× 64 0.3× 116 1.9k
Mark J. Dresser United States 24 1.3k 1.1× 697 1.1× 258 0.8× 147 0.6× 517 2.5× 49 2.5k
Alice A. Gibson United States 23 790 0.7× 391 0.6× 158 0.5× 69 0.3× 261 1.3× 46 1.4k
Crystal N. Holick United States 21 687 0.6× 314 0.5× 260 0.8× 100 0.4× 221 1.1× 38 1.8k

Countries citing papers authored by Floris A. de Jong

Since Specialization
Citations

This map shows the geographic impact of Floris A. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floris A. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floris A. de Jong more than expected).

Fields of papers citing papers by Floris A. de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floris A. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floris A. de Jong. The network helps show where Floris A. de Jong may publish in the future.

Co-authorship network of co-authors of Floris A. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Floris A. de Jong. A scholar is included among the top collaborators of Floris A. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Floris A. de Jong. Floris A. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munter, Johan De, et al.. (2023). The role of cancer nurses in cancer-related pain management in Europe. Palliative Care and Social Practice. 17. 386514788–386514788. 4 indexed citations
2.
Mahalingam, Devalingam, Manish R. Patel, Jasgit C. Sachdev, et al.. (2020). Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours. British Journal of Clinical Pharmacology. 86(9). 1836–1848. 49 indexed citations
3.
Chen, Li‐Tzong, Teresa Macarulla, Jean-Frédéric Blanc, et al.. (2020). Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1. Pancreatology. 21(1). 192–199. 8 indexed citations
4.
5.
Hubner, Richard, Antonio Cubillo, Jean‐Frédéric Blanc, et al.. (2018). Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. European Journal of Cancer. 106. 24–33. 36 indexed citations
6.
Pelzer, Uwe, Jean‐Frédéric Blanc, Davide Melisi, et al.. (2017). Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis. British Journal of Cancer. 116(10). 1247–1253. 22 indexed citations
7.
8.
Baas, Jara M., et al.. (2013). Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report. Cancer Chemotherapy and Pharmacology. 73(2). 429–433. 11 indexed citations
9.
Eechoute, Karel, Martin N. Fransson, Floris A. de Jong, et al.. (2012). A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients. Clinical Cancer Research. 18(20). 5780–5787. 87 indexed citations
10.
Baas, Jara M., Henk‐Jan Guchelaar, Jannemieke Ouwerkerk, et al.. (2011). Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review. Cancer Treatment Reviews. 38(5). 505–514. 48 indexed citations
11.
Bol, Jessica M. van der, Walter J. Loos, Floris A. de Jong, et al.. (2011). Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study. European Journal of Cancer. 47(6). 831–838. 16 indexed citations
12.
Bol, Jessica M. van der, Ron H.J. Mathijssen, Geert-Jan Creemers, et al.. (2010). A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan. Clinical Cancer Research. 16(2). 736–742. 50 indexed citations
13.
Bol, Jessica M. van der, Theo J. Visser, Walter J. Loos, et al.. (2010). Effects of methimazole on the elimination of irinotecan. Cancer Chemotherapy and Pharmacology. 67(1). 231–236. 6 indexed citations
14.
Jong, Floris A. de, Jessica M. van der Bol, Ron H.J. Mathijssen, et al.. (2007). Irinotecan chemotherapy during valproic acid treatment: Pharmacokinetic interaction and hepatotoxicity. Cancer Biology & Therapy. 6(9). 1364–1370. 22 indexed citations
15.
Engels, Frederike K., Floris A. de Jong, Ron H.J. Mathijssen, et al.. (2007). Medicinal cannabis in oncology. European Journal of Cancer. 43(18). 2638–2644. 24 indexed citations
16.
Perik, Patrick J., Bart Rikhof, Floris A. de Jong, et al.. (2007). Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity. Annals of Oncology. 19(2). 359–361. 45 indexed citations
17.
Jong, Floris A. de, Alex Sparreboom, Walter J. Loos, et al.. (2005). Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11). Cancer Research. 65. 938–939. 5 indexed citations
18.
Jong, Floris A. de, Maja J.A. de Jonge, Jaap Verweij, & Ron H.J. Mathijssen. (2005). Role of pharmacogenetics in irinotecan therapy. Cancer Letters. 234(1). 90–106. 90 indexed citations
19.
Jong, Floris A. de, Ron H.J. Mathijssen, & Jaap Verweij. (2004). Limited Potential of Hepatic Arterial Infusion of Irinotecan. Journal of Chemotherapy. 16(sup5). 48–50. 3 indexed citations
20.
Jong, Floris A. de, Ron H.J. Mathijssen, Peter de Bruijn, et al.. (2003). Determination of irinotecan (CPT-11) and SN-38 in human whole blood and red blood cells by liquid chromatography with fluorescence detection. Journal of Chromatography B. 795(2). 383–388. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacy S. Shord Breakdown of academic impact, for papers by Donna S. Cox Breakdown of academic impact, for papers by Clara Chen Breakdown of academic impact, for papers by Hyeong‐Seok Lim Breakdown of academic impact, for papers by Mansour Al‐Moundhri Breakdown of academic impact, for papers by Junichi Sakamoto Breakdown of academic impact, for papers by Hyun Jo Youn Breakdown of academic impact, for papers by Mark J. Dresser Breakdown of academic impact, for papers by Alice A. Gibson Breakdown of academic impact, for papers by Crystal N. Holick
Rankless by CCL
2026